User profiles for Anna Bershteyn
 | Anna BershteynNew York University School of Medicine Verified email at alum.mit.edu Cited by 5366 |
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
A major limitation of cell therapies is the rapid decline in viability and function of the
transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation of …
transplanted cells. Here we describe a strategy to enhance cell therapy via the conjugation of …
[HTML][HTML] Sustainable HIV treatment in Africa through viral-load-informed differentiated care
There are inefficiencies in current approaches to monitoring patients on antiretroviral
therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical …
therapy in sub-Saharan Africa. Patients typically attend clinics every 1 to 3 months for clinical …
[HTML][HTML] Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy
The efficacy of antiretroviral therapy is significantly compromised by medication non-adherence.
Long-acting enteral systems that can ease the burden of daily adherence have not yet …
Long-acting enteral systems that can ease the burden of daily adherence have not yet …
[HTML][HTML] Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
…, M Morrison, M Doherty, K Marsh, A Bershteyn… - The lancet HIV, 2020 - thelancet.com
Background The COVID-19 pandemic could lead to disruptions to provision of HIV services
for people living with HIV and those at risk of acquiring HIV in sub-Saharan Africa, where …
for people living with HIV and those at risk of acquiring HIV in sub-Saharan Africa, where …
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
Vaccines based on recombinant proteins avoid the toxicity and antivector immunity associated
with live vaccine (for example, viral) vectors, but their immunogenicity is poor, particularly …
with live vaccine (for example, viral) vectors, but their immunogenicity is poor, particularly …
[HTML][HTML] HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa
Background Many mathematical models have investigated the impact of expanding access
to antiretroviral therapy (ART) on new HIV infections. Comparing results and conclusions …
to antiretroviral therapy (ART) on new HIV infections. Comparing results and conclusions …
[HTML][HTML] Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 …
Background New WHO guidelines recommend initiation of antiretroviral therapy for HIV-positive
adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …
adults with CD4 counts of 500 cells per μL or less, a higher threshold than was …
Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial
RV Barnabas, ER Brown, A Bershteyn… - Annals of internal …, 2021 - acpjournals.org
Background: Effective prevention against coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently limited to …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is currently limited to …
Trajectory of viral RNA load among persons with incident SARS-CoV-2 G614 infection (Wuhan strain) in association with COVID-19 symptom onset and severity
…, PJ Kissinger, A Bershteyn… - JAMA Network …, 2022 - jamanetwork.com
Importance The SARS-CoV-2 viral trajectory has not been well characterized in incident
infections. These data are needed to inform natural history, prevention practices, and …
infections. These data are needed to inform natural history, prevention practices, and …
[HTML][HTML] Community-based antiretroviral therapy versus standard clinic-based services for HIV in South Africa and Uganda (DO ART): a randomised trial
…, KK Thomas, O Koole, A Bershteyn… - The lancet Global …, 2020 - thelancet.com
Background Community-based delivery of antiretroviral therapy (ART) for HIV, including ART
initiation, clinical and laboratory monitoring, and refills, could reduce barriers to treatment …
initiation, clinical and laboratory monitoring, and refills, could reduce barriers to treatment …